Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Clinical and adipocytokine changes after bariatric surgery in morbidly obese women.

Auguet T, Terra X, Hernández M, Sabench F, Porras JA, Orellana-Gavaldà JM, Llutart J, Guiu-Jurado E, Berlanga A, Martinez S, Aguilar C, Castillo DD, Richart C.

Obesity (Silver Spring). 2014 Jan;22(1):188-94. doi: 10.1002/oby.20470. Epub 2013 Jul 23.

2.

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.

Int J Obes (Lond). 2005 Jul;29(7):766-71.

PMID:
15917853
3.

Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects.

Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H.

Obes Facts. 2013;6(2):193-202. doi: 10.1159/000351162. Epub 2013 Apr 20.

PMID:
23615494
4.

Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery.

Marantos G, Daskalakis M, Karkavitsas N, Matalliotakis I, Papadakis JA, Melissas J.

World J Surg. 2011 Sep;35(9):2022-30. doi: 10.1007/s00268-011-1165-9.

PMID:
21691870
5.

The insulin tolerance test in morbidly obese patients undergoing bariatric surgery.

Geloneze B, Tambascia MA, Pareja JC, Repetto EM, Magna LA.

Obes Res. 2001 Dec;9(12):763-9.

6.

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2892-6. doi: 10.1210/jc.2009-2374. Epub 2010 Apr 7.

PMID:
20375212
7.

Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.

Gannagé-Yared MH, Yaghi C, Habre B, Khalife S, Noun R, Germanos-Haddad M, Trak-Smayra V.

Eur J Endocrinol. 2008 Mar;158(3):353-9. doi: 10.1530/EJE-07-0797.

8.

Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients.

Vilarrasa N, Vendrell J, Sánchez-Santos R, Broch M, Megia A, Masdevall C, Gomez N, Soler J, Pujol J, Bettónica C, Aranda H, Gómez JM.

Clin Endocrinol (Oxf). 2007 Nov;67(5):679-86. Epub 2007 Jul 2.

PMID:
17608757
9.

Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.

Auguet T, Terra X, Porras JA, Orellana-Gavaldà JM, Martinez S, Aguilar C, Lucas A, Pellitero S, Hernández M, Del Castillo D, Richart C.

Clin Biochem. 2013 Feb;46(3):202-8. doi: 10.1016/j.clinbiochem.2012.11.006. Epub 2012 Nov 19.

PMID:
23174488
10.

Relation of visfatin to cardiovascular risk factors and adipocytokines in patients with impaired fasting glucose.

de Luis DA, Sagrado MG, Conde R, Aller R, Izaola O.

Nutrition. 2013 Nov-Dec;29(11-12):1300-3. doi: 10.1016/j.nut.2008.11.005. Epub 2009 Jan 8.

PMID:
19131213
11.

Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery.

Karbaschian Z, Hosseinzadeh-Attar MJ, Giahi L, Golpaie A, Masoudkabir F, Talebpour M, Kosari F, Karbaschian N, Hoseini M, Mazaherioun M.

Endocrine. 2013 Aug;44(1):114-8. doi: 10.1007/s12020-012-9821-x. Epub 2012 Oct 28.

PMID:
23104149
12.

Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women.

Tsukui S, Kanda T, Nara M, Nishino M, Kondo T, Kobayashi I.

Int J Obes Relat Metab Disord. 2000 Sep;24(9):1207-11.

PMID:
11033992
13.

Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery.

Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR.

Diabetes Obes Metab. 2014 Dec;16(12):1230-8. doi: 10.1111/dom.12376. Epub 2014 Sep 14.

14.

Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients.

Piché MÈ, Martin J, Cianflone K, Bastien M, Marceau S, Biron S, Hould FS, Poirier P.

Metabolism. 2014 Jan;63(1):79-86. doi: 10.1016/j.metabol.2013.09.004. Epub 2013 Oct 10.

PMID:
24120264
15.

The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery.

Botella-Carretero JI, Luque-Ramírez M, Alvarez-Blasco F, Peromingo R, San Millán JL, Escobar-Morreale HF.

Obes Surg. 2008 Aug;18(8):1000-6. doi: 10.1007/s11695-007-9369-7. Epub 2008 Mar 19.

PMID:
18350343
16.

Impact of vertical banded gastroplasty on body weight, insulin resistance, adipocytokine, inflammation and metabolic syndrome markers in morbidly obese patients.

Jankiewicz-Wika J, Kołomecki K, Cywiński J, Piestrzeniewicz K, Swiętosławski J, Stępień H, Komorowski J.

Endokrynol Pol. 2011;62(2):109-19.

17.

Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.

Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC 3rd, Moody FG, Lux TR, Taegtmeyer H.

Am J Med. 2009 May;122(5):435-42. doi: 10.1016/j.amjmed.2008.10.035.

18.

Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery.

Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragón-Alonso A, Pascual-Díaz M, Pérez-Paredes M, Lozano-Almela ML.

Obes Surg. 2012 Jun;22(6):950-5. doi: 10.1007/s11695-012-0643-y.

PMID:
22527592
19.

Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women.

Simón I, Escoté X, Vilarrasa N, Gómez J, Fernández-Real JM, Megía A, Gutiérrez C, Gallart L, Masdevall C, Vendrell J.

Obesity (Silver Spring). 2009 Jun;17(6):1124-8. doi: 10.1038/oby.2008.665. Epub 2009 Feb 5.

20.

Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population?

Vilarrasa N, Vendrell J, Maravall J, Elío I, Solano E, San José P, García I, Virgili N, Soler J, Gómez JM.

Endocrine. 2010 Oct;38(2):235-42. doi: 10.1007/s12020-010-9379-4. Epub 2010 Jul 23.

PMID:
21046484
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk